Dbv technologies to report full year 2023 financial results and business update on march 7, 2024

Montrouge, france, march 4, 2024 dbv technologies to report full year 2023 financial results and business update on march 7, 2024 dbv technologies (euronext: dbv – isin: fr0010417345 – nasdaq stock market: dbvt), a clinical-stage biopharmaceutical company focused on treatments for food allergies, today announced the company will host a conference call and live audio webcast on thursday, march 7th, at 5:00 p.m. et to review full year 2023 financial results and provide a business update.
DBVT Ratings Summary
DBVT Quant Ranking